Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Evofem Biosciences Inc (EVFM)  
$1.00 0.00 (0.00%) as of 4:30 Thu 6/15


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 35,380,000
Market Cap: 35.38(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1 - $1.25
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Evofem Biosciences is a commercial-stage biopharmaceutical company committed to developing and commercializing products to address unmet needs in women's sexual and reproductive health, including woman-controlled contraception and protection from certain sexually transmitted infections. Co.'s commercial product, Phexxi, is the U.S. Food and Drug Administration (FDA)-approved, hormone-free, woman-controlled, prescription contraceptive gel for women. Co. is evaluating Phexxi for two potential new indications: the prevention of chlamydia and the prevention of gonorrhea in women. The FDA has designated Phexxi, using the investigational name EVO100, as a Qualified Infectious Disease Product.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 114 114 114
Total Sell Value $0 $10 $10 $10
Total People Sold 0 2 2 2
Total Sell Transactions 0 2 2 2
End Date 2024-02-29 2023-11-28 2023-05-30 2022-05-30

   
Records found: 194
  Page 6 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Culwell Kelly Chief Medical Officer   •       –      –    2019-02-25 4 A $0.00 $0 D/D 50,000 61,985     -
   Barrans Russell Chief Commercial Officer   •       –      –    2019-02-25 4 A $0.00 $0 D/D 75,000 87,541     -
   Pelletier Saundra L Chief Executive Officer   •       •      –    2019-02-25 4 A $0.00 $0 D/D 150,000 491,813     -
   Invesco Ltd. 10% Owner   –       –       •   2019-02-08 4 B $2.64 $1,123,402 I/I 425,531 9,590,688 1.5     -
   Barrans Russell Chief Commercial Officer   •       –      –    2018-11-21 4 B $3.55 $990 I/I 279 12,820 1.91     -
   Fitzpatrick Alexander A General Counsel and Secretary   •       –      –    2018-10-16 4 D $3.78 $65,685 D/D (17,377) 57,623     -
   Fitzpatrick Alexander A General Counsel and Secretary   •       –      –    2018-08-21 4 B $2.27 $1,135 D/D 500 75,000 2.66     -
   Fitzpatrick Alexander A General Counsel and Secretary   •       –      –    2018-08-20 4 B $2.20 $9,900 D/D 4,500 74,500 2.74     -
   Culwell Kelly Chief Medical Officer   •       –      –    2018-08-16 4 B $2.24 $6,720 D/D 3,000 11,985 2.74     -
   Lynch Thomas G Director   –       •      –    2018-08-15 4 B $2.33 $160,605 D/D 68,929 175,000 2.39     -
   Lynch Thomas G Director   –       •      –    2018-08-14 4 B $2.10 $65,249 D/D 31,071 106,071 2.39     -
   Pelletier Saundra L Chief Executive Officer   •       •      –    2018-08-10 4 B $2.11 $21,100 D/D 10,000 341,813 2.81     -
   Barrans Russell Chief Commercial Officer   •       –      –    2018-08-10 4 B $1.98 $7,356 D/D 3,715 12,541 2.74     -
   File Justin J. Chief Financial Officer   •       –      –    2018-07-02 4 D $2.46 $293,995 D/D (119,510) 180,490     -
   File Justin J. Chief Financial Officer   •       –      –    2018-07-02 4 A $0.00 $0 D/D 300,000 300,000     -
   Pelletier Saundra L Chief Executive Officer   •       •      –    2018-07-02 4 D $2.46 $1,213,240 D/D (493,187) 331,813     -
   Pelletier Saundra L Chief Executive Officer   •       •      –    2018-07-02 4 A $0.00 $0 D/D 825,000 825,000     -
   Culwell Kelly Chief Medical Officer   •       –      –    2018-07-02 4 D $2.46 $11,680 D/D (4,748) 8,985     -
   Culwell Kelly Chief Medical Officer   •       –      –    2018-07-02 4 A $0.00 $0 D/D 13,733 13,733     -
   Barrans Russell Chief Commercial Officer   •       –      –    2018-07-02 4 D $2.46 $6,986 D/D (2,840) 8,826     -
   Barrans Russell Chief Commercial Officer   •       –      –    2018-07-02 4 A $0.00 $0 D/D 11,666 11,666     -
   Fitzpatrick Alexander A General Counsel and Secretary   •       –      –    2018-07-02 4 A $0.00 $0 D/D 70,000 70,000     -
   Lynch Thomas G Director   –       •      –    2018-07-02 4 OE $0.00 $0 D/D 75,000 75,000     -
   Invesco Ltd. 10% Owner   –       –       •   2018-05-22 4 B $4.69 $9,978,721 I/I 2,127,659 9,165,157 1.5     -
   Demski Martha J Director   –       •      –    2016-06-21 4 OE $1.13 $18,524 D/D 16,393 16,393     -
  194 Records found
  1  2  3  4  5  6  7  8   
  Page 6 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us